Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE
Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.
Dual-energy CT systems allow for significant reduction in contrast dose
DECT systems allow for a contrast dose reduction of up to 25% during computed tomography pulmonary angiography exams.
Connecticut hospital hit with $32M judgment after cow-based formula linked to infant’s death
Yale New Haven failed to notify parents about the use of the cow-based formula, which they expressly asked staff not to use. A judge found that the hospital failed to stock a human alternative, known to be safer for premature newborns.
FDA to add ‘black box’ warning to COVID vaccines, report says
The label is the most serious warning the agency can place on pharmaceuticals, denoting substances that carry serious health risks that must be weighed against benefits. CNN was the first to report the news, citing two sources familiar with the matter.
FDA clears next-generation cardiac mapping software
San Diego-based Vektor Medical first secured FDA clearance for the AI-powered technology back in 2021. This updated announcement covers the latest version, which includes atrial flutter mapping and several other new features.

Pulmonary embolism AI cleared

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

3D cardiac modeling solution for VT ablation receives FDA clearance

The new software solution was designed with ventricular tachycardia ablation and other cardiac ablation procedures in mind.

Empagliflozin may reverse vascular aging, lower CVD risk

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

Some respiratory face masks are unsafe for MRIs, study finds

Five out of eight filtering face piece (FFP-3) masks studied contained ferromagnetic components.

Anagrelide capsules FDA recall Teva Pharmaceuticals USA

FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes

The medication failed a routine dissolution test, meaning it could lose its effectiveness.

Surgeon General warns of healthcare workforce burnout

A new advisory from the U.S. Surgeon General included several recommendations for addressing burnout.

FDA posts guidance on managing risk of drug shortages

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

The FDFA has cleared tirzepatide (Mounjaro) from Eli Lilly for the treatment of diabetes.

FDA approves tirzepatide, Eli Lilly’s new type 2 diabetes drug, and the company shares an estimated price

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Clinical

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

Dual-energy CT systems allow for significant reduction in contrast dose

Connecticut hospital hit with $32M judgment after cow-based formula linked to infant’s death

FDA to add ‘black box’ warning to COVID vaccines, report says

FDA clears next-generation cardiac mapping software